Volumetric burden of metastatic lesions drives outcomes in patients with extracranial oligometastatic disease.

The total volumetric burden of metastases at initial OM presentation to SBRT is strongly and independently prognostic for the risk of distant and widespread progression and survival. We propose that this metric should drive the definition of OM disease and guide treatment decision-making.